ClinicalTrials.Veeva

Find clinical trials for Non-Small-Cell Lung Cancer in Philadelphia, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Lung Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Colorectal Cancer
Triple Negative Breast Cancer

Non-Small-Cell Lung Cancer trials near Philadelphia, PA, USA:

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...

Enrolling
Metastatic Non Small Cell Lung Cancer
Biological: LN-145

Phase 2

Iovance Biotherapeutics

Camden, New Jersey, United States and 41 other locations

INCMGA00012 in participants with metastatic squamous and nonsquamous non-small cell lung cancer (NSCLC)....

Active, not recruiting
Metastatic Nonsquamous Non-Small Cell Lung Cancer
Metastatic Squamous Non-Small Cell Lung Cancer
Drug: nab-Paclitaxel
Drug: Paclitaxel

Phase 3

Incyte
Incyte

Reading, Pennsylvania, United States and 140 other locations

and radiation therapy in treating patients with stage II-IIIB non-small cell lung cancer. Monoclonal ant...

Active, not recruiting
Stage IIIA Non-Small Cell Lung Cancer
Stage IIIB Non-Small Cell Lung Cancer
Other: Laboratory Biomarker Analysis
Drug: Carboplatin

Phase 1

Rutgers The State University of New Jersey
Rutgers The State University of New Jersey

Philadelphia, Pennsylvania, United States and 2 other locations

previously untreated for advanced or metastatic, PD-L1 positive non-small cell lung cancer (NSCLC). The ...

Enrolling
Non-small Cell Lung Cancer
Drug: Pembrolizumab (MK-3475) 200 mg
Device: NovoTTF-200T

Phase 2

NovoCure
NovoCure

Wynnewood, Pennsylvania, United States and 23 other locations

and osimertinib in subjects with locally advanced or metastatic non-small cell lung cancer (NSCLC) with ...

Enrolling
Non-Small Cell Lung Cancer (NSCLC)
Drug: Osimertinib
Drug: HER3-DXd

Phase 1

Daiichi Sankyo
Daiichi Sankyo

Philadelphia, Pennsylvania, United States and 30 other locations

This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Telisotuzumab vedotin

Phase 2

AbbVie
AbbVie

Pennington, New Jersey, United States and 252 other locations

combination with standard of care carboplatin and pemetrexed) in 21 day treatment cycle for participants with advanced non-small c ...

Active, not recruiting
Non-Small-Cell Lung Cancer
Drug: Amivantamab
Drug: Pemetrexed

Phase 1

Janssen
Janssen

Philadelphia, Pennsylvania, United States and 72 other locations

alone for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung ...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Pemetrexed/Carboplatin
Drug: Pemetrexed/Cisplatin

Phase 3

AstraZeneca
AstraZeneca

Philadelphia, Pennsylvania, United States and 152 other locations

This is a Phase III, randomised, double-blind, multicentre, international study assessing the efficacy and safety of durvalumab (MEDI4736) in combina...

Enrolling
Non-Small Cell Lung Cancer
Drug: Oleclumab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Philadelphia, Pennsylvania, United States and 227 other locations

in participants with Programmed death ligand-1 (PD L-1) high (Tumor cells [TC]/ Tumor proportion score [TPS] ≥ 50%), previously untreated, u...

Enrolling
Lung Cancer, Non-Small Cell
Drug: Belrestotug
Drug: GSK6097608

Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Wynnewood, Pennsylvania, United States and 120 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems